multiple myeloma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

multiple myeloma
Dec 24, 2024, 11:33 | Blog
Muhammad Umair Mushtaq: Utilizing CAR-T therapy in relapsed/refractory multiple myeloma
Muhammad Umair Mushtaq, Associate Professor of Medicine at University of Kansas Medical Center, shared a…
Dec 22, 2024, 13:29 | Science
Outpatient teclistamab step-up dosing in Multiple Myeloma
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a recent article by Tyler…
Dec 22, 2024, 10:00 | Science
Francesco Maura: CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma
Francesco Maura, Assistant Professor of Sylvester Comprehensive Cancer Center, posted on X about recent paper…
Dec 21, 2024, 22:26 | Blog
Anas Younes: Transforming outcomes for people living with Blood Cancer
Anas Younes, Senior VP, Global Head of Hematology (Early and Late Stage), Oncology R&D at…
Dec 16, 2024, 17:18 | Blog
Rahul Banerjee: Antibody targets in smoldering multiple myeloma analyzed
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted the following on X: “Fascinating…
Dec 16, 2024, 08:42 | Blog
PETHEMA-GEM experience highlights cytogenetic abnormalities in multiple myeloma
Muzaffar Qazilbash, Stem Cell Transplant Physician and Clinical Researcher at MD Anderson Cancer Center, shared…
Dec 14, 2024, 15:32 | Insight
Myeloma Paper of the Day, December 14th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Analysis of smoldering…
Dec 13, 2024, 17:37 | Blog
Moffitt Cancer Center - Potential avenues for toxicity prevention and therapeutic optimization in high-risk patients
Moffitt Cancer Center shared on LinkedIn: "In a packed ASH24 session, Doris Hansen, presented a comprehensive…
Dec 12, 2024, 20:10 | Blog
Urvi Shah was awarded the ASH's David M. Goldenberg Clinical Research Training Institute Award
Memorial Sloan Kettering Cancer Center shared on LinkedIn "Congratulations to Dr. Urvi Shah, a myeloma…
Dec 11, 2024, 14:33 | Blog
Sabrina Hanna: Visiting Kite Pharma's CAR T-Cell Manufacturing Facility
Sabrina Hanna, Chief change officer at The Cancer Collaborative and Executive Director of Save Your…
Dec 11, 2024, 13:21 | Insight
Myeloma Paper of the Day, December 11th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: AQUILA study shows patients…
Dec 11, 2024, 12:41 | Blog
Robert Orlowski on patients with newly diagnosed multiple myeloma to benefit from Isa-VRd as initiation therapy
MD Anderson Cancer Center shared on X: "Patients with newly diagnosed multiple myeloma may benefit from…
Dec 10, 2024, 13:33 | Blog
Rahul Banerjee: Robert Z. Orlowski presented updated IMROZ MRD Multiple Myeloma data
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted on X: "ASH24 well, this…
Dec 10, 2024, 12:41 | Blog
Nikhil Vojjala: Racial representation among studies for MM NCCN guidelines
Nikhil Vojjala, MD in Internal Medicine at Trinity Health MI, shared a post on X:…
Dec 10, 2024, 07:06 | Blog
Samer Al Hadidi: Discontinuation of Lenalidomide Maintenance after ASCT in MM
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X: “Oral…
Dec 9, 2024, 17:55 | Blog
Shahrin Ahmed: The treatment of multiple myeloma is being improved
Shahrin Ahmed, Medical Specialist oncology at Canadian Cancer Society and Associate Professor at Staffordshire University,…
Dec 9, 2024, 14:30 | Insight
Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory Multiple Myeloma
Mohamed Benlazar, Professor of Hematology at Sidi Bel Abbès University Hospital, shared a article by…
Dec 8, 2024, 06:51 | Insight
Nico Gagelmann: Suggesting Bispecific Antibodies as Standard of Care for Relapse After CAR-T in Multiple Myeloma
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a recent article on X: "Finally out…
Dec 4, 2024, 21:31 | Blog
Join us in supporting cancer researchers this Giving Tuesday - ASCO
ASCO - American Society of Clinical Oncology reposted a post by Conquer Cancer, the ASCO…
Dec 4, 2024, 14:15 | Insight
Myeloma Paper of the Day, December 4th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: A systematic review and meta-analysis…
Nov 30, 2024, 15:51 | Insight
Myeloma Paper of the Day, November 30th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: High level of circulating cell-free…
Nov 21, 2024, 16:11 | Blog
Mike Thompson: Myeloma/Plasma Cell Dyscrasia - Top Abstract Highlights from ASH24
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a post on X:…
Nov 21, 2024, 14:56 | Insight
Samer Al Hadidi: Immune microenvironment alterations in Multiple Myeloma
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X: “Check…
Nov 18, 2024, 17:13 | Blog
Vincent Rajkumar: Working on refining response criteria in myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared a post on…
Nov 17, 2024, 12:23 | Insight
Samer Al Hadidi: Quadruplets as Top Option in Transplant-Ineligible Multiple Myeloma
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on LinkedIn: "Quadruplets…
Nov 13, 2024, 10:52 | Blog
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO/DARZALEX…
Nov 12, 2024, 17:56 | Insight
Daratumumab+ Lenalidomide vs Lenalidomide for Post-Transplant Maintenance in Multiple Myeloma
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a recent article by…
Nov 12, 2024, 15:53 | Insight
Myeloma Paper of the Day, November 12th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Study of predictors of local…
Nov 8, 2024, 13:40 | Insight
Myeloma Paper of the Day, November 8th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Results of a Phase 1b…
Nov 1, 2024, 15:23 | Insight
Myeloma Paper of the Day, November 1st, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Integrated functional genomic analysis of…
Oct 31, 2024, 15:16 | Insight
Myeloma Paper of the Day, October 31st, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Forimtamig, a novel…
Oct 31, 2024, 06:01 | Insight
Nico Gagelmann: Bs Abs as bridging to BCMA CAR-T cell therapy for R/R multiple myeloma
Nico Gagelmann, Co- Chair of the The EBMT Trainee Committee, shared on X: “Finally out!…
Oct 30, 2024, 15:18 | Insight
Myeloma Paper of the Day, October 30th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Retrospective evaluation of…
Oct 27, 2024, 11:46 | Blog
Vincent Rajkumar: Key recommendations for CART and bispecifics for relapsed myeloma
Vincent Rajkumar posted on X: "Key recommendations for CART and bispecifics for relapsed myeloma presented…
Oct 22, 2024, 23:30 | Blog
Murali Janakiram: Common questions about Bispecifics and CART in Multiple Myeloma
Murali Janakiram, Associate Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City…
Oct 19, 2024, 13:59 | Insight
Myeloma Paper of the Day, October 19th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Case series of patients…
Oct 18, 2024, 12:58 | Blog
Rahul Banerjee: Multicenter description of immune effector cell-associated enterocolitis as a novel toxicity of CAR T-cell therapy in multiple myeloma
Rahul Banerjee shared a post on X, about recent paper published in Blood Cancer Journal:…
Oct 16, 2024, 14:56 | Blog
5th How to Diagnose and Treat: Multiple Myeloma
5th How to Diagnose and Treat: Multiple Myeloma will be held at Vienna Austria from…
Oct 16, 2024, 14:26 | Blog
Rahul Banerjee: An area where we need more research!
Rahul Banerjee shared a post by Nature Medicine on X, adding the following: “Relevant to…
Oct 14, 2024, 11:47 | Blog
Honoring John Gallin, the 10th and longest-serving director of the NIH Clinical Center
John I. Gallin, M.D., the 10th director of the National Institutes of Health (NIH) Clinical…
Oct 12, 2024, 16:23 | Insight
Myeloma Paper of the Day, October 12th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Pharmacovigilance study of…
Oct 11, 2024, 16:19 | Insight
Myeloma Paper of the Day, October 11th, suggested by Robert Orlowski
Robert Orlowski shared about the Myeloma Paper of the Day. Read about the article on…
Oct 9, 2024, 12:36 | Insight
Myeloma Paper of the Day, October 9th, suggested by Robert Orlowski
Robert Orlowski shared about the Myeloma Paper of the Day. Read about the article on…
Oct 4, 2024, 17:11 | Blog
Registration opens for the 7th Translational Research Conference on Multiple Myeloma - ESH
ESH (European School of Haematology) shared a post on X: ''Our Team is ready to…
Oct 4, 2024, 15:20 | Insight
Rahul Banerjee: Dexamethasone 40mg weekly in Multiple Myeloma induction
Rahul Banerjee shared his recent article on X: "Grateful to Blood Journal, co-authors, and SWOG…
Sep 30, 2024, 18:22 | Blog
Rahul Banerjee: Don’t say “atypical abnormal” unless it is
Rahul Banerjee shared a post on X: "IMS24 see the future of FISH reporting in Multiple…
Sep 24, 2024, 11:34 | Blog
Rahul Banerjee: A picture worth a thousand words
Rahul Banerjee shared a post on X, about recent paper published in The Lancet Haematology:…
Sep 23, 2024, 16:26 | Blog
Tom Snow: The FDA approved our combination therapy for adults with newly diagnosed Multiple Myeloma
Olivier Nataf, Global Head of Oncology at Sanofi, shared a post by Tom Snow on…
Sep 20, 2024, 14:26 | Blog
Malin Hultcrantz: Colesevelam for treatment of lenalidomide associated diarrhea
Elias K. Mai, Board Certified Specialist in Internal Medicine, Hematology and Oncology at University Hospital…
Sep 20, 2024, 08:50 | Insight
Santiago Thibaud: Multiple Myeloma Risk and Outcomes Associated with PGVs in DNA Repair Genes
Santiago Thibaud shared on X: "New paper in Blood Cancer Discovery! Thrilled to announce our…
Sep 18, 2024, 14:06 | Blog
Maximilian Merz: A comeback of checkpoint inhibition in Multiple Myeloma
Maximilian Merz, Head of Early Clinical Trials Unit Leipzig (ECTUL) at Leipzig University, shared a…
Sep 17, 2024, 14:23 | Insight
Myeloma Paper of the Day, September 17th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: A phase I study of MAGE-A1-targeted…
Sep 10, 2024, 10:28 | Blog
Matthew Herper: Facing cancer is hard -- even if you're someone who would change the way we treat cancer
Matthew Herper, Senior Writer, Medicine, and Editorial Director, Events at STAT, made the following post…
Sep 9, 2024, 09:26 | Blog
Rahul Banerjee: AURIGA results in IMS 2024 app
Rahul Banerjee shared a post on X: ''AURIGA results in the International Myeloma Society (IMS)…
Sep 8, 2024, 10:38 | Insight
Myeloma Paper of the Day, September 8th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Retrospective case-control study with Korea National Health…
Sep 7, 2024, 14:48 | Insight
MD Anderson Research Highlights
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Sep 5, 2024, 15:19 | Insight
Myeloma Paper of the Day, September 5th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Metformin augments GPRC5D expression in…
Sep 5, 2024, 00:05 | Blog
The International Myeloma Foundation has helped bring over 17 treatments for multiple myeloma to market
International Myeloma Foundation shared a post on X: “The International Myeloma Foundation has helped bring…
Sep 1, 2024, 15:09 | Blog
Joselle Cook: Raising awareness for multiple myeloma at the annual Minneapolis MMRF WALK
Joselle Cook, Assistant Professor of Medicine at Mayo Clinic, shared a post on X: ''We’re…
Sep 1, 2024, 08:24 | Insight
Rahul Banerjee: Chronicle disparities in Relapsed or Refractory myeloma and why they matter
Rahul Banerjee shared on X: "Now in Blood Cancer Journal - our work to chronicle…
Aug 29, 2024, 11:32 | Blog
The upcoming IACH event for Patients in French
IACH (International Academy for Clinical Hematology) shared a post on X: ''Join us for the…
Aug 27, 2024, 09:40 | Insight
Myeloma Paper of the Day, August 27th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Study using cryo-EM to elucidate…
Aug 25, 2024, 20:14 | Blog
CPOEM Foundation's first support group webinar for patients with multiple myeloma
CPOEM Foundation posted on LinkedIn: "We kicked off our first support group webinar on August…
Aug 24, 2024, 07:20 | Blog
Saad Usmani joins the ICE expedition to raise money for MM research - IMF
International Myeloma Foundation (IMF) shared a post on X: "Dr. Saad Usmani joins the ICE (Iceland…
Aug 23, 2024, 13:45 | Insight
Myeloma Paper of the Day, August 23rd, suggested by Robert Orlowski
Robert Z. Orlowski shared a post on X: "Myeloma Paper of the Day: Study of teclistamab…
Aug 23, 2024, 12:25 | Insight
Jonathan Keats: 12 Days of CoMMpass – Day 4
Jonathan Keats shared on X: “12 Days of CoMMpass – Day 4: Today we will…
Aug 22, 2024, 16:01 | Blog
Annual Updates in the Management of Multiple Myeloma - UNC Lineberger Cancer Network
UNC Lineberger Cancer Network posted on X: "Samuel M. Rubinstein, MD, MSCI, presents on Annual…
Aug 22, 2024, 04:05 | Insight
Jonathan Keats: 12 Days of CoMMpass - Day 2
Jonathan Keats shared on X: “12 Days of CoMMpass – Day 2: The intention of…
Aug 21, 2024, 13:44 | Insight
MMRF Fast Facts in Myeloma Series
Multiple Myeloma Research Foundation shared on X: “Our MMRF Fast Facts in Myeloma series is…
Aug 20, 2024, 14:29 | Blog
Rahul Banerjee: What's the best unifying term for the equivalent of bridging therapy but before apheresis?
Rahul Banerjee shared a poll on X: "Maybe more of a CAR-T consensus here than…
Aug 15, 2024, 04:56 | Blog
Hung Trinh: A novel CAR-Enhancer to prevent relapse after CAR-T Therapy by Dana-Farber Cancer Institute
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Aug 14, 2024, 10:29 | Insight
Rahul Banerjee: They say not all MRD negativity in myeloma is created equal
Rahul Banerjee shared on X: "They say not all MRD negativity in myeloma is created…
Aug 14, 2024, 07:24 | Career
Christine Ryland as Director of Thought Leader Liaison for the multiple myeloma team at Kite Pharma
Christine Ryland shared on LinkedIn: "I’m happy to share that I have started a new position…
Aug 13, 2024, 12:34 | Insight
Myeloma Paper of the Day, August 13th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Nationwide registry study of patients…
Aug 12, 2024, 22:03 | Blog
Rahul Banerjee: Timothy Schmid about whole-body MRI imaging in multiple myeloma at DAVA Heme
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "DAVA Heme and now Timothy…
Aug 12, 2024, 12:52 | Blog
Erik Ellefsen: Got to share a bit of my myeloma story at OCS and met another myeloma warrior
Erik Ellefsen, Cancer Survivor and Patient Advocate, shared on X: "Got to share a bit…
Aug 12, 2024, 12:46 | Blog
Rahul Banerjee: Sanam Loghavi is the best pathologist in the world
Sanam Loghavi shared a post by Rahul Banerjee, Assistant Professor at UW Medicine, on X: "Have…
Aug 12, 2024, 03:20 | Blog
Using lymphocyte count to predict CAR-T cell therapy efficacy in relapsed multiple myeloma
WCM Myeloma Center posted on X: "New research led by Drs. Mateo Mejia, Ruben Niesvizky…
Aug 11, 2024, 19:32 | Blog
Samer Al Hadidi: Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, posted on X about recent paper…
Aug 11, 2024, 13:16 | Insight
Myeloma Paper of the Day, August 11th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Super enhancer acquisition drives expression…
Aug 10, 2024, 11:10 | Insight
Shahrin Ahmed: Multiple myeloma treatment with Darzalex Faspro has been approved by the FDA
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: "Multiple…
Aug 9, 2024, 13:46 | Blog
Highlights from DAVA Oncology Translational Summit on Hematologic Malignancies
3rd Translational Summit on Hematologic Malignancies by DAVA Oncology is formatted to foster discussion and…
Aug 8, 2024, 10:11 | Blog
Nico Gagelmann: Fast and furious: CAR-T cells in multiple myeloma
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at The…
Aug 7, 2024, 01:13 | Insight
Rahul Banerjee's perspectives on approval of daratumumab and hyaluronidase plus VRd in MM
Oncology Data Advisor shared on X: "Did you hear about last week's approval of daratumumab…
Aug 5, 2024, 10:33 | Blog
Experts in multiple myeloma discuss exciting updates presented at the 2024 ASCO Annual Meeting - Cancer Network
Cancer Network shared on LinkedIn: "Experts in multiple myeloma look to the future treatment landscape…
Aug 2, 2024, 12:09 | Societies
Rahul Banerjee: ASH24 advice for everyone going through the ASH dash
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "ASH24 advice for everyone going through the…
Aug 2, 2024, 07:55 | Blog
The CEO of the IMF joins Chadi Nabhan to talk about his Multiple Myeloma at the age of 25
Chadi Nabhan, Medical Director of The University of Chicago Medical Center, shared on X: "Stay tuned…
Aug 1, 2024, 08:32 | Insight
Rahul Banerjee: A 'CAR-E' - basically a care package for CAR T-cells as they start their first jobs
Rahul Banerjee, Assistant Professor at UW Medicine, shared a posts by Mohammad Rashidian, Assistant Professor, Dana-Farber Cancer Institute,…
Aug 1, 2024, 07:52 | Blog
Hole in One for Multiple Myeloma Golf Tournament - International Myeloma Foundation
International Myeloma Foundation shared a post on X: ''Join us for the Hole in One…
Aug 1, 2024, 07:11 | Blog
No two cases of multiple myeloma are alike, making treatment decisions a challenge - The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research shared a post on X, about a recent paper…
Aug 1, 2024, 04:52 | Blog
Rahul Banerjee: Pleasure to be interviewed with Betsy O'Donnell about patient support group
Rahul Banerjee, Graduate Research Assistant at Duke University Pratt School of Engineering, shared CURE Today's…
Jul 31, 2024, 08:28 | Blog
Sonia Guedan: The CAR-T ARI0002h by IDIBAPS has been approved for multiple myeloma
Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, shared a post on X: ''The CAR-T ARI0002h…
Jul 29, 2024, 20:59 | Blog
Murali Janakiram: Practical tips from Joseph Mikhael for Quad induction in multiple myeloma
Murali Janakiram, Associate Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City…
Jul 28, 2024, 15:35 | Insight
IgG replacement in myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, shared a paper by Rafael Fonseca et al on…
Jul 28, 2024, 12:28 | Insight
Ross Firestone: Antigen escape with BCMA-targeting therapies in multiple myeloma
Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared a post on X…
Jul 28, 2024, 10:33 | Blog
Mark your agenda for ESHMM 2025
The European School of Haematology (ESH) shared on X: "Mark your agenda for ESHMM 2025:…
Jul 27, 2024, 22:17 | Insight
A blood test that may predict if people with relapsed MM are going to respond well to CAR-T immunotherapy - Weill Cornell Medicine
Weill Cornell Medicine shared on X: "A blood test that measures the number of lymphocytes…
Jul 27, 2024, 11:33 | Blog
Hamza Hashmi: Looking forward to this ASCO Direct CME event
Hamza Hashmi, Myeloma and Cellular Therapy physician at Memorial Sloan Kettering Cancer Centre, shared on…
Jul 25, 2024, 14:07 | Insight
Learn how Carl Ola Landgren is creating a risk profile to personalize myeloma care - HealthTree Foundation
HealthTree Foundation shared on X: "Learn how Dr. C. Ola Landgren and his colleagues at…
Jul 25, 2024, 00:36 | Blog
Diana Romero: AI, exploiting bacteria, multiple myeloma and more in the new issue of Nature Reviews Clinical Oncology
Diana Romero, Chief Editor at Nature Research, shared on LinkedIn: "A new issue of Nature…
All: 247 Posts: 1 - 100
Special Coverage